European Medical Journal 3.2 2018

| View in Fullscreen

In this issue

Volume 3, Issue 2 Contents

Page Number Title Authors
Features
12-15 Plotting a Better Pathway for Parkinson’s Disease: A New Composite Scale from My PD Journey Graham L et al.
Symposium Reviews 
17-24 Delivering Precision Medicine and Patient-Centred Care Through a Multidisciplinary Approach Olga Ulcar
25-33 Treating Psoriasis: What Is New About Fumaric Acid Esters? Amanda Pedder
34-41 Anti-Tumour Necrosis Factor in Inflammatory Bowel Disease: Inventory and Outlook Laura Bella and Phil Ford
Articles
42-29 Editor’s Pick: Pyruvate Kinase and Gastric Cancer: A Potential Marker Macedo F et al.
50-59 Slowing Progression of Airway Diseases by Smoking Cessation and Reducing Infections Lewis K et al.
60-68 Initiatives to Improve Safety of Oral Anticancer Agents Delivered by Community Pharmacists Meier K et al.
70-77 Overactive Bladder in Children Rhaiana Gondim Oliveira, Ubirajara Barroso, Jr
78-89 Multiple Myeloma: Personalised Medicine Based on Pathogenesis Yang WC et al.
90-99 Modern Methods for Studying Portal Hypertension-Associated Angiogenesis in Experimental Research Arefyev NO et al.
100-107 Management of Non-Small Cell Lung Cancer: The Era of Immunotherapy Tiziana Vavalà
108-118 Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review Jennifer Gallacher, Stuart McPherson
119-125 New Insights into the Role of Phosphoinositide 3-Kinase Activity in the Physiology of Immature Oocytes: Lessons from Recent Mouse Model Studies So-Youn Kim, Takeshi Kurita
126-134 The Adverse Impact of Sarcopenia and Visceral Fat Deposition on the Course of Hepatocellular Carcinoma and the Role of Nutritional Interventions McCulloch A et al.